PROXY STATEMENT

Company

TG THERAPEUTICS, INC.

Filed

September 5, 2000

Period of Report

September 29, 2000

Accession Number

0000922423-00-001112

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →